331 related articles for article (PubMed ID: 17410438)
1. Hypermethylation of SFRP2 as a potential marker for stool-based detection of colorectal cancer and precancerous lesions.
Huang Z; Li L; Wang J
Dig Dis Sci; 2007 Sep; 52(9):2287-91. PubMed ID: 17410438
[TBL] [Abstract][Full Text] [Related]
2. SFRP2 methylation in fecal DNA--a marker for colorectal polyps.
Oberwalder M; Zitt M; Wöntner C; Fiegl H; Goebel G; Zitt M; Köhle O; Mühlmann G; Ofner D; Margreiter R; Müller HM
Int J Colorectal Dis; 2008 Jan; 23(1):15-9. PubMed ID: 17639423
[TBL] [Abstract][Full Text] [Related]
3. Detection of aberrant methylation in fecal DNA as a molecular screening tool for colorectal cancer and precancerous lesions.
Huang ZH; Li LH; Yang F; Wang JF
World J Gastroenterol; 2007 Feb; 13(6):950-4. PubMed ID: 17352030
[TBL] [Abstract][Full Text] [Related]
4. Combined detection of plasma GATA5 and SFRP2 methylation is a valid noninvasive biomarker for colorectal cancer and adenomas.
Zhang X; Song YF; Lu HN; Wang DP; Zhang XS; Huang SL; Sun BL; Huang ZG
World J Gastroenterol; 2015 Mar; 21(9):2629-37. PubMed ID: 25759530
[TBL] [Abstract][Full Text] [Related]
5. Stool methylation-specific polymerase chain reaction assay for the detection of colorectal neoplasia in Korean patients.
Baek YH; Chang E; Kim YJ; Kim BK; Sohn JH; Park DI
Dis Colon Rectum; 2009 Aug; 52(8):1452-9; discussion 1459-63. PubMed ID: 19617759
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic and prognostic value of the methylation status of secreted frizzled-related protein 2 in colorectal cancer.
Tang D; Liu J; Wang DR; Yu HF; Li YK; Zhang JQ
Clin Invest Med; 2011 Apr; 34(2):E88-95. PubMed ID: 21463549
[TBL] [Abstract][Full Text] [Related]
7. Sensitive and Noninvasive Detection of Aberrant SFRP2 and MGMT-B Methylation in Iranian Patients with Colon Polyps.
Naini MA; Mokarram P; Kavousipour S; Zare N; Atapour A; Zarin1 MH; Mehrabani G; Borji M
Asian Pac J Cancer Prev; 2016; 17(4):2185-93. PubMed ID: 27221916
[TBL] [Abstract][Full Text] [Related]
8. Detection of promoter hypermethylation of Wnt antagonist genes in fecal samples for diagnosis of early colorectal cancer.
Zhang H; Zhu YQ; Wu YQ; Zhang P; Qi J
World J Gastroenterol; 2014 May; 20(20):6329-35. PubMed ID: 24876755
[TBL] [Abstract][Full Text] [Related]
9. Hypermethylated SFRP2 gene in fecal DNA is a high potential biomarker for colorectal cancer noninvasive screening.
Wang DR; Tang D
World J Gastroenterol; 2008 Jan; 14(4):524-31. PubMed ID: 18203283
[TBL] [Abstract][Full Text] [Related]
10. Comparison of a prototype reverse hybridization assay and MethyLight for detection of SFRP2 promotor methylation in fecal DNA.
Kriegshäuser G; Enko D; Zitt M; Oberwalder M; Oberkanins C; Öfner D; Zeillinger R; Maximilian Müller H
Int J Biol Markers; 2017 Oct; 32(4):e467-e470. PubMed ID: 28777432
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation analysis of secreted frizzled-related protein 2 gene for the early detection of colorectal cancer in fecal DNA.
Babaei H; Mohammadi M; Salehi R
Niger Med J; 2016; 57(4):242-5. PubMed ID: 27630389
[TBL] [Abstract][Full Text] [Related]
12. The variation trends of SFRP2 methylation of tissue, feces, and blood detection in colorectal cancer development.
Sui C; Ma J; Chen Q; Yang Y
Eur J Cancer Prev; 2016 Jul; 25(4):288-98. PubMed ID: 26258809
[TBL] [Abstract][Full Text] [Related]
13. DNA stool test for colorectal cancer: hypermethylation of the secreted frizzled-related protein-1 gene.
Zhang W; Bauer M; Croner RS; Pelz JO; Lodygin D; Hermeking H; Stürzl M; Hohenberger W; Matzel KE
Dis Colon Rectum; 2007 Oct; 50(10):1618-26; discussion 1626-7. PubMed ID: 17762966
[TBL] [Abstract][Full Text] [Related]
14. Variation risks of SFRP2 hypermethylation between precancerous disease and colorectal cancer.
Sui C; Wang G; Chen Q; Ma J
Tumour Biol; 2014 Oct; 35(10):10457-65. PubMed ID: 25053594
[TBL] [Abstract][Full Text] [Related]
15. The importance of stool DNA methylation in colorectal cancer diagnosis: A meta-analysis.
Mojtabanezhad Shariatpanahi A; Yassi M; Nouraie M; Sahebkar A; Varshoee Tabrizi F; Kerachian MA
PLoS One; 2018; 13(7):e0200735. PubMed ID: 30024936
[TBL] [Abstract][Full Text] [Related]
16. A novel method to capture methylated human DNA from stool: implications for colorectal cancer screening.
Zou H; Harrington J; Rego RL; Ahlquist DA
Clin Chem; 2007 Sep; 53(9):1646-51. PubMed ID: 17712002
[TBL] [Abstract][Full Text] [Related]
17. Detection of colorectal neoplasm using promoter methylation of ITGA4, SFRP2, and p16 in stool samples: a preliminary report in Korean patients.
Chang E; Park DI; Kim YJ; Kim BK; Park JH; Kim HJ; Cho YK; Sohn CI; Jeon WK; Kim BI; Kim HD; Kim DH; Kim YH
Hepatogastroenterology; 2010; 57(101):720-7. PubMed ID: 21033217
[TBL] [Abstract][Full Text] [Related]
18. Feasibility of quantifying
Oh TJ; Oh HI; Seo YY; Jeong D; Kim C; Kang HW; Han YD; Chung HC; Kim NK; An S
Clin Epigenetics; 2017; 9():126. PubMed ID: 29225717
[TBL] [Abstract][Full Text] [Related]
19. Detection of hypermethylated DNA or cyclooxygenase-2 messenger RNA in fecal samples of patients with colorectal cancer or polyps.
Leung WK; To KF; Man EP; Chan MW; Hui AJ; Ng SS; Lau JY; Sung JJ
Am J Gastroenterol; 2007 May; 102(5):1070-6. PubMed ID: 17378912
[TBL] [Abstract][Full Text] [Related]
20. Analysis of fecal DNA methylation to detect gastrointestinal neoplasia.
Nagasaka T; Tanaka N; Cullings HM; Sun DS; Sasamoto H; Uchida T; Koi M; Nishida N; Naomoto Y; Boland CR; Matsubara N; Goel A
J Natl Cancer Inst; 2009 Sep; 101(18):1244-58. PubMed ID: 19700653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
